|
US5521297A
(en)
*
|
1993-06-04 |
1996-05-28 |
Salk Institute Biotechnology/Industrial Associates |
Nucleic acids encoding human metabotropic glutamate receptors
|
|
US5981195A
(en)
*
|
1995-07-26 |
1999-11-09 |
Nps Pharmaceuticals, Inc. |
Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors
|
|
US6221609B1
(en)
*
|
1996-07-03 |
2001-04-24 |
Eli Lilly And Company |
Isolate nucleic acid encoding human MGLUR8
|
|
US7262280B1
(en)
|
1998-04-03 |
2007-08-28 |
Nps Pharmaceuticals, Inc. |
G-protein fusion receptors and constructs encoding same
|
|
EP1066325A1
(en)
*
|
1998-04-03 |
2001-01-10 |
Nps Pharmaceuticals, Inc. |
G-protein fusion receptors and chimeric gaba b? receptors
|
|
EP1662255A3
(en)
*
|
1998-08-18 |
2006-09-13 |
The Johns Hopkins University School Of Medicine |
Homer interacting proteins
|
|
EP1105734A4
(en)
*
|
1998-08-18 |
2005-04-13 |
Univ Johns Hopkins Med |
PROTEINS WITH INTERACTION OF THE HOMER FAMILY
|
|
IL141691A0
(en)
*
|
1998-08-31 |
2002-03-10 |
Trinity College Dublin |
Polypeptides and polynucleotides from coagulase-negative staphylococci
|
|
US20030166554A1
(en)
*
|
2001-01-16 |
2003-09-04 |
Genset, S.A. |
Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
|
|
US20030185754A1
(en)
*
|
2001-01-16 |
2003-10-02 |
Genset, S.A. |
Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
|
|
US6620850B2
(en)
*
|
2001-09-19 |
2003-09-16 |
University Of Florida |
Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors
|
|
US20050233321A1
(en)
*
|
2001-12-20 |
2005-10-20 |
Hess John W |
Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
|
|
CA2472472A1
(en)
*
|
2002-01-10 |
2003-07-24 |
Osteotrophin Llc |
Treatment of bone disorders with skeletal anabolic drugs
|
|
WO2004050858A2
(en)
*
|
2002-12-04 |
2004-06-17 |
Diadexus, Inc. |
Compositions, splice variants and methods relating to colon specific genes and proteins
|
|
US20050186658A1
(en)
*
|
2003-10-17 |
2005-08-25 |
Nps Pharmaceuticals, Inc. |
Chimeric metabotropic glutamate receptors and uses thereof
|
|
WO2005073730A1
(en)
*
|
2004-01-31 |
2005-08-11 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human metabotropic glutamate receptor 8 (mglur8)
|
|
AU2005295655A1
(en)
*
|
2004-10-14 |
2006-04-27 |
Carnegie Institution Of Washington |
Neurotransmitter sensors and methods of using the same
|
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
|
US8889950B2
(en)
*
|
2006-07-28 |
2014-11-18 |
The George Washington University |
Repression of AtGLR3.2 increases plant biomass
|
|
US7424876B2
(en)
*
|
2006-10-06 |
2008-09-16 |
Ford Global Technologies, Llc |
Pushrod engine with multiple independent lash adjusters for each pushrod
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
PL2203439T3
(pl)
|
2007-09-14 |
2011-06-30 |
Addex Pharmaceuticals Sa |
1',3'-dipodstawione-4-fenylo-3,4,5,6-tetrahydro-2H, 1'H-[1, 4']bipirydynylo-2'-ketony
|
|
CA2707309A1
(en)
*
|
2007-12-18 |
2009-06-25 |
Acumen Pharmaceuticals, Inc. |
Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production
|
|
AU2009274482A1
(en)
*
|
2008-05-20 |
2010-01-28 |
Eos Neuroscience, Inc. |
Vectors for delivery of light-sensitive proteins and methods of use
|
|
JP5547194B2
(ja)
|
2008-09-02 |
2014-07-09 |
ジャンセン ファーマシューティカルズ， インコーポレイテッド． |
代謝型グルタミン酸受容体の調節因子としての３−アザビシクロ［３．１．０］ヘキシル誘導体
|
|
RU2512283C2
(ru)
|
2008-11-28 |
2014-04-10 |
Янссен Фармасьютикалз, Инк. |
Производные индола и бензоксазина в качестве модуляторов метаботропных глутаматных рецепторов
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
KR101753826B1
(ko)
|
2009-05-12 |
2017-07-04 |
얀센 파마슈티칼즈, 인코포레이티드 |
1,２,４―트리아졸로［４,３―ａ］피리딘 유도체 및 신경정신 질환의 치료 또는 예방을 위한 이들의 용도
|
|
AU2010246607B2
(en)
|
2009-05-12 |
2012-09-27 |
Addex Pharma S.A. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
|
CN103261195B
(zh)
|
2010-11-08 |
2015-09-02 |
杨森制药公司 |
1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
|
|
CA2815002C
(en)
|
2010-11-08 |
2019-10-22 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
AU2011328194B2
(en)
|
2010-11-08 |
2015-04-16 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
LT3431106T
(lt)
|
2014-01-21 |
2021-02-10 |
Janssen Pharmaceutica Nv |
Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas
|
|
SI3431106T1
(sl)
|
2014-01-21 |
2021-03-31 |
Janssen Pharmaceutica Nv |
Kombinacije, ki vsebujejo pozitivne alosterične modulatorje metabotropnega glutamatergičnega receptorja podtipa 2 in njihova uporaba
|
|
NZ739721A
(en)
|
2015-08-07 |
2019-09-27 |
Imaginab Inc |
Antigen binding constructs to target molecules
|
|
WO2018147960A1
(en)
|
2017-02-08 |
2018-08-16 |
Imaginab, Inc. |
Extension sequences for diabodies
|
|
CA3060443A1
(en)
|
2017-04-19 |
2018-10-25 |
Board Of Regents, The University Of Texas System |
Immune cells expressing engineered antigen receptors
|
|
JP7273421B2
(ja)
|
2018-02-21 |
2023-05-15 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
ナチュラルキラー細胞の活性化および拡大のための方法ならびにその使用
|